[1]
Katan M, Luft A. Global Burden of Stroke. Seminars in neurology. 2018 Apr:38(2):208-211. doi: 10.1055/s-0038-1649503. Epub 2018 May 23
[PubMed PMID: 29791947]
[2]
Guzik A, Bushnell C. Stroke Epidemiology and Risk Factor Management. Continuum (Minneapolis, Minn.). 2017 Feb:23(1, Cerebrovascular Disease):15-39. doi: 10.1212/CON.0000000000000416. Epub
[PubMed PMID: 28157742]
[3]
Boehme AK, Esenwa C, Elkind MS. Stroke Risk Factors, Genetics, and Prevention. Circulation research. 2017 Feb 3:120(3):472-495. doi: 10.1161/CIRCRESAHA.116.308398. Epub
[PubMed PMID: 28154098]
[4]
O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, Mondo C, Damasceno A, Lopez-Jaramillo P, Hankey GJ, Dans AL, Yusoff K, Truelsen T, Diener HC, Sacco RL, Ryglewicz D, Czlonkowska A, Weimar C, Wang X, Yusuf S, INTERSTROKE investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (London, England). 2010 Jul 10:376(9735):112-23. doi: 10.1016/S0140-6736(10)60834-3. Epub 2010 Jun 17
[PubMed PMID: 20561675]
Level 2 (mid-level) evidence
[5]
Towfighi A. Stroke Prevention. Seminars in neurology. 2017 Jun:37(3):235-236. doi: 10.1055/s-0037-1603947. Epub 2017 Jul 31
[PubMed PMID: 28759905]
[6]
Dufouil C, Beiser A, McLure LA, Wolf PA, Tzourio C, Howard VJ, Westwood AJ, Himali JJ, Sullivan L, Aparicio HJ, Kelly-Hayes M, Ritchie K, Kase CS, Pikula A, Romero JR, D'Agostino RB, Samieri C, Vasan RS, Chêne G, Howard G, Seshadri S. Revised Framingham Stroke Risk Profile to Reflect Temporal Trends. Circulation. 2017 Mar 21:135(12):1145-1159. doi: 10.1161/CIRCULATIONAHA.115.021275. Epub 2017 Feb 3
[PubMed PMID: 28159800]
[7]
Musuka TD, Wilton SB, Traboulsi M, Hill MD. Diagnosis and management of acute ischemic stroke: speed is critical. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2015 Sep 8:187(12):887-93. doi: 10.1503/cmaj.140355. Epub 2015 Aug 4
[PubMed PMID: 26243819]
[11]
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL, American Heart Association Stroke Council. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018 Mar:49(3):e46-e110. doi: 10.1161/STR.0000000000000158. Epub 2018 Jan 24
[PubMed PMID: 29367334]
[12]
Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet (London, England). 2008 May 10:371(9624):1612-23. doi: 10.1016/S0140-6736(08)60694-7. Epub
[PubMed PMID: 18468545]
[13]
Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends in neurosciences. 1999 Sep:22(9):391-7
[PubMed PMID: 10441299]
[15]
Mărgăritescu O, Mogoantă L, Pirici I, Pirici D, Cernea D, Mărgăritescu C. Histopathological changes in acute ischemic stroke. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie. 2009:50(3):327-39
[PubMed PMID: 19690757]
[16]
DeGracia DJ. 'Functional histology' in brain ischemia studies. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2011 Aug:31(8):1661-2. doi: 10.1038/jcbfm.2011.40. Epub 2011 Mar 30
[PubMed PMID: 21448216]
[17]
de Oliveira JL, Crispin Pd, Duarte EC, Marloch GD, Gargioni R, Trentin AG, Alvarez-Silva M. Histopathology of motor cortex in an experimental focal ischemic stroke in mouse model. Journal of chemical neuroanatomy. 2014 May:57-58():1-9. doi: 10.1016/j.jchemneu.2014.03.002. Epub 2014 Mar 21
[PubMed PMID: 24662146]
[19]
Sporns PB, Hanning U, Schwindt W, Velasco A, Minnerup J, Zoubi T, Heindel W, Jeibmann A, Niederstadt TU. Ischemic Stroke: What Does the Histological Composition Tell Us About the Origin of the Thrombus? Stroke. 2017 Aug:48(8):2206-2210. doi: 10.1161/STROKEAHA.117.016590. Epub 2017 Jun 16
[PubMed PMID: 28626055]
[20]
Romano JG, Smith EE, Liang L, Gardener H, Camp S, Shuey L, Cook A, Campo-Bustillo I, Khatri P, Bhatt DL, Fonarow GC, Sacco RL, Schwamm LH. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry. JAMA neurology. 2015 Apr:72(4):423-31. doi: 10.1001/jamaneurol.2014.4354. Epub
[PubMed PMID: 25642650]
Level 2 (mid-level) evidence
[21]
Campbell BCV, Ma H, Ringleb PA, Parsons MW, Churilov L, Bendszus M, Levi CR, Hsu C, Kleinig TJ, Fatar M, Leys D, Molina C, Wijeratne T, Curtze S, Dewey HM, Barber PA, Butcher KS, De Silva DA, Bladin CF, Yassi N, Pfaff JAR, Sharma G, Bivard A, Desmond PM, Schwab S, Schellinger PD, Yan B, Mitchell PJ, Serena J, Toni D, Thijs V, Hacke W, Davis SM, Donnan GA, EXTEND, ECASS-4, and EPITHET Investigators. Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data. Lancet (London, England). 2019 Jul 13:394(10193):139-147. doi: 10.1016/S0140-6736(19)31053-0. Epub 2019 May 22
[PubMed PMID: 31128925]
Level 1 (high-level) evidence
[22]
Kate M, Gioia L, Buck B, Sivakumar L, Jeerakathil T, Shuaib A, Butcher K. Dabigatran Therapy in Acute Ischemic Stroke Patients Without Atrial Fibrillation. Stroke. 2015 Sep:46(9):2685-7. doi: 10.1161/STROKEAHA.115.010383. Epub 2015 Jul 30
[PubMed PMID: 26304866]
[23]
Barreto AD, Ford GA, Shen L, Pedroza C, Tyson J, Cai C, Rahbar MH, Grotta JC, ARTSS-2 Investigators. Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke). Stroke. 2017 Jun:48(6):1608-1616. doi: 10.1161/STROKEAHA.117.016720. Epub 2017 May 15
[PubMed PMID: 28507269]
Level 1 (high-level) evidence
[24]
Wilson D, Ambler G, Banerjee G, Shakeshaft C, Cohen H, Yousry TA, Al-Shahi Salman R, Lip GYH, Houlden H, Brown MM, Muir KW, Jäger HR, Werring DJ, Clinical relevance of Microbleeds in Stroke (CROMIS-2) collaborators. Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study. Journal of neurology, neurosurgery, and psychiatry. 2019 Mar:90(3):320-325. doi: 10.1136/jnnp-2018-318890. Epub 2018 Nov 19
[PubMed PMID: 30455404]
[25]
Whiteley WN, Adams HP Jr, Bath PM, Berge E, Sandset PM, Dennis M, Murray GD, Wong KS, Sandercock PA. Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. The Lancet. Neurology. 2013 Jun:12(6):539-45. doi: 10.1016/S1474-4422(13)70079-6. Epub 2013 May 2
[PubMed PMID: 23642343]
Level 1 (high-level) evidence
[26]
Sandercock PA,Counsell C,Kane EJ, Anticoagulants for acute ischaemic stroke. The Cochrane database of systematic reviews. 2015 Mar 12;
[PubMed PMID: 25764172]
Level 1 (high-level) evidence
[27]
Yi X, Lin J, Wang C, Zhang B, Chi W. Low-molecular-weight heparin is more effective than aspirin in preventing early neurologic deterioration and improving six-month outcome. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2014 Jul:23(6):1537-44. doi: 10.1016/j.jstrokecerebrovasdis.2013.12.036. Epub 2014 Mar 19
[PubMed PMID: 24656240]
[28]
Dennis M, Caso V, Kappelle LJ, Pavlovic A, Sandercock P, European Stroke Organisation. European Stroke Organisation (ESO) guidelines for prophylaxis for venous thromboembolism in immobile patients with acute ischaemic stroke. European stroke journal. 2016 Mar:1(1):6-19. doi: 10.1177/2396987316628384. Epub 2016 Mar 1
[PubMed PMID: 31008263]
[29]
Seiffge DJ, Werring DJ, Paciaroni M, Dawson J, Warach S, Milling TJ, Engelter ST, Fischer U, Norrving B. Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation. The Lancet. Neurology. 2019 Jan:18(1):117-126. doi: 10.1016/S1474-4422(18)30356-9. Epub 2018 Nov 8
[PubMed PMID: 30415934]
[30]
Jeong HG,Kim BJ,Yang MH,Han MK,Bae HJ,Lee SH, Stroke outcomes with use of antithrombotics within 24 hours after recanalization treatment. Neurology. 2016 Sep 6;
[PubMed PMID: 27521435]
[31]
Altavilla R, Caso V, Bandini F, Agnelli G, Tsivgoulis G, Yaghi S, Furie KL, Tadi P, Becattini C, Zedde M, Abdul-Rahim AH, Lees KR, Alberti A, Venti M, Acciarresi M, D'Amore C, Mosconi MG, Anna Cimini L, Fusaro J, Bovi P, Carletti M, Rigatelli A, Cappellari M, Putaala J, Tomppo L, Tatlisumak T, Marcheselli S, Pezzini A, Poli L, Padovani A, Masotti L, Vannucchi V, Sohn SI, Lorenzini G, Tassi R, Guideri F, Acampa M, Martini G, Ntaios G, Athanasakis G, Makaritsis K, Karagkiozi E, Vadikolias K, Liantinioti C, Chondrogianni M, Mumoli N, Consoli D, Galati F, Sacco S, Carolei A, Tiseo C, Corea F, Ageno W, Bellesini M, Silvestrelli G, Ciccone A, Lanari A, Scoditti U, Denti L, Mancuso M, Maccarrone M, Ulivi L, Orlandi G, Giannini N, Gialdini G, Tassinari T, De Lodovici ML, Bono G, Rueckert C, Baldi A, D'Anna S, Toni D, Letteri F, Giuntini M, Maria Lotti E, Flomin Y, Pieroni A, Kargiotis O, Karapanayiotides T, Monaco S, Maimone Baronello M, Csiba L, Szabó L, Chiti A, Giorli E, Del Sette M, Imberti D, Zabzuni D, Doronin B, Volodina V, Michel P, Vanacker P, Barlinn K, Pallesen LP, Barlinn J, Deleu D, Melikyan G, Ibrahim F, Akhtar N, Gourbali V, Paciaroni M. Anticoagulation After Stroke in Patients With Atrial Fibrillation. Stroke. 2019 Aug:50(8):2093-2100. doi: 10.1161/STROKEAHA.118.022856. Epub 2019 Jun 21
[PubMed PMID: 31221054]
Level 3 (low-level) evidence
[32]
Friberg L, Rosenqvist M, Lip GY. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study. Circulation. 2012 May 15:125(19):2298-307. doi: 10.1161/CIRCULATIONAHA.111.055079. Epub 2012 Apr 18
[PubMed PMID: 22514252]